A carregar...
Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma
BACKGROUND: To explore the efficacy and safety of crizotinib versus platinum‐based double agent chemotherapy as the first‐line treatment in patients with advanced anaplastic lymphoma kinase (ALK)‐positive lung adenocarcinoma. METHOD: We retrospectively analyzed data from 19 patients with advanced AL...
Na minha lista:
| Publicado no: | Thorac Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718131/ https://ncbi.nlm.nih.gov/pubmed/26816533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12264 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|